Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans

American Journal of Managed Care

Volumn 16, Issue 5, 2010, Pages 351-360

  Haque, Reina ^a   Achacoso, Ninah S ^b   Fletcher, Suzanne W ^c,e   Nekhlyudov, Larissa ^c,e   Collins, Laura C ^d   Schnitt, Stuart J ^d,e   Quesenberry Jr , Charles P ^b   Habel, Laurel A ^b  

^a Kaiser Permanente Southern California   (United States)

^b DIVISION OF RESEARCH   (United States)

^c HARVARD PILGRIM HEALTH CARE   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; BODY MASS; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOMA IN SITU; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; HEALTH INSURANCE; HISPANIC; HUMAN; INCOME; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL RECORD REVIEW; NEGRO; PACIFIC ISLANDER; PALPATION; PRIORITY JOURNAL; RACE DIFFERENCE; TUMOR GROWTH; TUMOR NECROSIS; TUMOR VOLUME; UNITED STATES;

AGED; CALIFORNIA; CARCINOMA, DUCTAL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MANAGED CARE PROGRAMS; MASSACHUSETTS; MEDICAL AUDIT; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS;

EID: 77952815049     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. American Cancer Society. SR2: Cancer Facts and Figures 2005. Atlanta, GA: American Cancer Society Inc; 2005.
2. Mokbel K, Cutuli B. Heterogeneity of ductal carcinoma in situ and its effects on management. Lancet Oncol. 2006;7(9):756-765. (Pubitemid 44283669)
3. Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev. 2005;14(4):1008-1011.
4. Li CL, Malone KE, Saltzman BS, Daling JR. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Cancer. 2006;106(10):2104-2112.
5. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334-357.
6. Joslyn SA. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival. Breast J. 2006:12(1):20-27.
7. Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst. 2004;96(12):906-920.
8. Bickell NA, Wang JJ, Oluwole S, et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006;24(9):1357-1362.
9. Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer. 2000;88(1):114-123.
10. Griggs JJ, Sorbero ME, Stark AT, Heininger SE, Dick AW. Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat. 2003;81(1):21-31. (Pubitemid 37108437)
11. Moormeier J. Breast cancer in black women. Ann Intern Med. 1996;124(10):897-905.
12. Joslyn SA. Racial differences in treatment and survival from early-stage breast carcinoma. Cancer. 2002;95(8):1759-1766.
13. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163(1):49-56. (Pubitemid 36091600)
14. Mandelblatt JS, Kerner JF, Hadley J, et al; OPTIONS (Outcomes and Preferences for Treatment in Older Women Nationwide Study). Variations in breast carcinoma treatment in older Medicare beneficiaries: is it black or white? Cancer. 2002;95:1401-1414.
15. Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med. 1992;326(17):1097-1101.
16. Ballard-Barbash R, Potosky AL, Harlan LC. Nayfield SG, Kessler LG. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst. 1996;88(11):716-726. (Pubitemid 26195019)
17. Riley GF, Potosky AL, Klabunde CN, Warren JL, Ballard-Barbash R. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA. 1999;281(8):720-726.
18. Innos K, Horn-Ross PL. Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women. Cancer. 2003;97(4):1099-1106. (Pubitemid 36173164)
19. Mokbel K. Contemporary treatment of ductal carcinoma in situ of the breast. Med Sci Monit. 2005;11(3):RA86-RA93.
20. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet. 1999;353(9169):1993-2000.
21. Bijker N, Peterse JL, Fentiman IS, et al. Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS. Br J Cancer. 2002;87(6):615-620.
22. Du XL, Key CR, Osborne C. Community-based assessment of adjuvant hormone therapy in women with breast cancer, 1991-1997. Breast J. 2004;10(5):433-439.
23. Malin JL, Schuster MA, Kahn KA, Brook RH. Quality of breast cancer care: what do we know? J Clin Oncol. 2002;20(21):4381-4393.
24. Elmore JG, Nakano CY, Linden HM, Reisch LM, Ayanian JZ, Larson EB. Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care. 2005;43(2):141-148.
25. Du X, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: the advantages of the linked Medicare and SEER data: Surveillance, Epidemiology and End Results. J Clin Epidemiol. 1999;52(5):463-470.
26. Gold HT, Thwin SS, Buist DS, et al. Delayed radiotherapy for breast cancer patients in integrated delivery systems. Am J Manag Care. 2009;15(11):785-789.
27. Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2004;96(6):443-448. (Pubitemid 38443647)
28. Gold HT, Dick AW. Variations in treatment for ductal carcinoma in situ in elderly women. Med Care. 2004;42(3):267-275.
29. van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer. 2007;120(9):1986-1992. (Pubitemid 46418378)
30. Kuijpens JL, Janssen-Heijnen ML, Lemmens VE, Haak HR, Heijckmann AC, Coebergh JW. Comorbidity in newly diagnosed thyroid cancer patients: a population-based study on prevalence and the impact on treatment and survival. Clin Endocrinol. 2006;64(4):450-455.
31. Krieger N, Waterman P, Lemieux K, Zierler S, Hogan JW. On the wrong side of the tracts? evaluating the accuracy of geocoding in public health research. Am J Public Health. 2001;91(7):1114-1116.
32. Oliver MN, Matthews KA, Siadaty M, Hauck FR, Pickle LW. Geographic bias related to geocoding in epidemiologic studies. Int J Health Geogr. 2005;4:e29.
33. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. Toronto, ON: John Wiley & Son Inc; 2000.
34. National Heart, Lung, and Blood Institute. Calculate your body mass index. http://www.nhlbisupport.com/bmi/. Accessed January 6, 2010.
35. SAS [computer program]. Version 9.1. Cary, NC: SAS Institute Inc; 2001.
36. Heimann R, Ferguson D, Powers C, Suri D, Weichselbaum RR, Hellman S. Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. J Clin Oncol. 1997;15(6):2329-2337.
37. Velanovich V, Yood MU, Bawle U, et al. Racial differences in the presentation and surgical management of breast cancer. Surgery. 1999;125(4):375-379.
38. Han I, Orton C, Shamsa F, Hart K, et al. Combined low-dose-rate brachytherapy and external beam radiation for cervical cancer: experience over ten years. Radiat Oncol Investig. 1999;7(5):289-296.
39. Franzini L, Williams AF, Franklin J, Singletary SE, Theriault RL. Effects of race and socioeconomic status on survival of 1,332 black, Hispanic, and white women with breast cancer. Ann Surg Oncol. 1997;4(2):111-118.
40. Logsdon MD, Eifel PJ. FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys. 1999;43(4):763-775.
41. Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005;97(6):439-448.
42. Enger SM, Thwin SS, Buist DS, et al. Breast cancer treatment of older women in integrated health care settings. J Clin Oncol. 2006;24(27):4377-4383.
43. Buist DS, Chubak J, Prout M, et al. Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence. J Clin Oncol. 2009;27(27):4508-4514.
44. West CN, Geiger AM, Greene SM, et al. Race and ethnicity: comparing medical records to self-reports. J Natl Cancer Inst Monogr. 2005;35:72-74.
45. Chen FM, Breiman RF, Farley M, Plikaytis B, Deaver K, Cetron MS. Geocoding and linking data from population-based surveillance and the US Census to evaluate the impact of median household income on the epidemiology of invasive Streptococcus pneumoniae infections. Am J Epidemiol. 1998;148(12):1212-1218.
46. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89(19):1406-1422.
47. Brenes GA, Paskett ED. Predictors and stage of adoption for colorectal cancer screening. Prev Med. 2000;31(4):410-416.
48. Partridge A, Adloff K, Blood E, et al. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst. 2008;100(4):243-251. ■